Items Tagged ‘Stages I-III Pancreatic Cancer’

May 10, 2011

Afinitor Approved for Pancreatic Neuroendocrine Tumors


The US Food and Drug Administration has approved Afinitor® (everolimus) for the treatment of advanced pancreatic neuroendocrine tumors (PNET). Pancreatic neuroendocrine tumors are a relatively uncommon type of cancer that develops in the hormone-producing cells of the pancreas. Afinitor is an oral targeted therapy that works by inhibiting a protein known as the mammalian target […]

View full entry

Tags: Pancreatic Cancer, Stage IV Pancreatic Cancer, Stages I-III Pancreatic Cancer